Improving transplant success and single cell analysis revealing cell state changes in prostate cancer

byMemorial Sloan Kettering Cancer CenterAn MSK scientist works in the lab. Credit: Memorial Sloan Kettering Cancer CenterNew research from Memorial Sloan Kettering Cancer Center (MSK) showed giv

Updated on: August 27,2024

Improving transplant success and single cell analysis revealing cell state changes in prostate cancer

byMemorial Sloan Kettering Cancer CenterAn MSK scientist works in the lab. Credit: Memorial Sloan Kettering Cancer CenterNew research from Memorial Sloan Kettering Cancer Center (MSK) showed giv

Updated on:August 27,2024

Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia

byOsaka Metropolitan UniversityEffect of the oral medication venetoclax after allogeneic hematopoietic cell transplantation. Credit: Osaka Metropolitan UniversityRelapsed/refractory acute myeloi

Updated on: August 01,2024

Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia

byOsaka Metropolitan UniversityEffect of the oral medication venetoclax after allogeneic hematopoietic cell transplantation. Credit: Osaka Metropolitan UniversityRelapsed/refractory acute myeloi

Updated on:August 01,2024

Computational tool integrates transcriptomic data to enhance breast cancer diagnosis and treatment

by Nik Papageorgiou,Ecole Polytechnique Federale de LausanneClinical validation of EMBER. Credit:npj Breast Cancer(2024). DOI: 10.1038/s41523-024-00665-zAddressing problems with diag

Updated on: August 03,2024

Computational tool integrates transcriptomic data to enhance breast cancer diagnosis and treatment

by Nik Papageorgiou,Ecole Polytechnique Federale de LausanneClinical validation of EMBER. Credit:npj Breast Cancer(2024). DOI: 10.1038/s41523-024-00665-zAddressing problems with diag

Updated on:August 03,2024

Study reveals aggressive prostate cancer linked to ancestral heritage

byUniversity of SydneyCredit:Nature(2022). DOI: 10.1038/s41586-022-05154-6Two pioneering studies published simultaneously today inNatureandGenome Medicine, have ide

Updated on: January 22,2024

Study reveals aggressive prostate cancer linked to ancestral heritage

byUniversity of SydneyCredit:Nature(2022). DOI: 10.1038/s41586-022-05154-6Two pioneering studies published simultaneously today inNatureandGenome Medicine, have ide

Updated on:January 22,2024

Pancreatic cancer tumor classification could optimize treatment choices

by UNC Lineberger Comprehensive Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA study from the University of North Caroli

Updated on: May 13,2024

Pancreatic cancer tumor classification could optimize treatment choices

by UNC Lineberger Comprehensive Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA study from the University of North Caroli

Updated on:May 13,2024

New study shows Black cancer survivors face increased mortality from heart disease

byAmerican Cancer SocietyCredit: American Cancer SocietyA new study from researchers at the American Cancer Society (ACS) found that Black cancer survivors in the United States experience a high

Updated on: January 12,2024

New study shows Black cancer survivors face increased mortality from heart disease

byAmerican Cancer SocietyCredit: American Cancer SocietyA new study from researchers at the American Cancer Society (ACS) found that Black cancer survivors in the United States experience a high

Updated on:January 12,2024

Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Credit: Pixabay/CC0 Public DomainShares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.Merck will

Updated on: March 08,2024

Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Credit: Pixabay/CC0 Public DomainShares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.Merck will

Updated on:March 08,2024

New imaging technique accurately detects aggressive kidney cancer

by Denise Heady,University of California, Los AngelesRepresentative imaging with [89Zr]Zr-girentuximab. Credit:The Lancet Oncology(2024). DOI: 10.1016/S1470-2045(24)00402-9A new stud

Updated on: November 10,2024

New imaging technique accurately detects aggressive kidney cancer

by Denise Heady,University of California, Los AngelesRepresentative imaging with [89Zr]Zr-girentuximab. Credit:The Lancet Oncology(2024). DOI: 10.1016/S1470-2045(24)00402-9A new stud

Updated on:November 10,2024

Night work may increase the risk of aggressive prostate cancer in offshore petroleum workers

by University of Oslo, Faculty of MedicineExposure-risk curve for a non-linear model of rollover shift work exposure, generated using restricted cubic splines with five knots (0.58, 3.82, 8.99, 14.98

Updated on: January 29,2024

Night work may increase the risk of aggressive prostate cancer in offshore petroleum workers

by University of Oslo, Faculty of MedicineExposure-risk curve for a non-linear model of rollover shift work exposure, generated using restricted cubic splines with five knots (0.58, 3.82, 8.99, 14.98

Updated on:January 29,2024

Research team develops novel strategy to suppress prostate cancer growth

by Aaron Nieto,Baylor College of MedicineProstate cancer cells. Credit: NIH Image GalleryFinding valuable therapeutic interventions for prostate cancer has long guided the research of Dr. Feng Y

Updated on: February 20,2024

Research team develops novel strategy to suppress prostate cancer growth

by Aaron Nieto,Baylor College of MedicineProstate cancer cells. Credit: NIH Image GalleryFinding valuable therapeutic interventions for prostate cancer has long guided the research of Dr. Feng Y

Updated on:February 20,2024

Newly developed inhibitor shows potential for prostate cancer

JANUARY 9, 2024byAlbert Ludwigs University of FreiburgIdentification of a bi-substrate inhibitor of KMT9.aChemical structure of compound1awith predicted binding mode.&nbs

Updated on: March 25,2024

Newly developed inhibitor shows potential for prostate cancer

JANUARY 9, 2024byAlbert Ludwigs University of FreiburgIdentification of a bi-substrate inhibitor of KMT9.aChemical structure of compound1awith predicted binding mode.&nbs

Updated on:March 25,2024

Scientists develop a rapid gene-editing screen to find effects of cancer mutations

by Massachusetts Institute of TechnologyDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHTumors can carry mutations in hundreds of different gen

Updated on: March 20,2024

Scientists develop a rapid gene-editing screen to find effects of cancer mutations

by Massachusetts Institute of TechnologyDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHTumors can carry mutations in hundreds of different gen

Updated on:March 20,2024